EMFAT
ICPT
Emerald Mutual Fund Advisers Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-129,878
| Closed | -$8.62M | – | 304 |
|
|
2019
Q3 | $8.62M | Sell |
129,878
-8,020
| -6% | -$532K | 0.38% | 99 |
|
|
2019
Q2 | $11M | Buy |
137,898
+27,080
| +24% | +$2.15M | 0.44% | 81 |
|
|
2019
Q1 | $12.4M | Buy |
+110,818
| New | +$12.4M | 0.5% | 68 |
|
|
2018
Q1 | – | Sell |
-115,679
| Closed | -$6.76M | – | 263 |
|
|
2017
Q4 | $6.76M | Buy |
+115,679
| New | +$6.76M | 0.27% | 128 |
|
|
2017
Q1 | – | Sell |
-65,654
| Closed | -$7.13M | – | 293 |
|
|
2016
Q4 | $7.13M | Buy |
65,654
+2,421
| +4% | +$263K | 0.34% | 107 |
|
|
2016
Q3 | $10.4M | Buy |
63,233
+21,742
| +52% | +$3.58M | 0.53% | 77 |
|
|
2016
Q2 | $5.92M | Buy |
41,491
+24,021
| +137% | +$3.43M | 0.33% | 109 |
|
|
2016
Q1 | $2.24M | Sell |
17,470
-8,930
| -34% | -$1.15M | 0.13% | 156 |
|
|
2015
Q4 | $3.94M | Sell |
26,400
-19,420
| -42% | -$2.9M | 0.21% | 135 |
|
|
2015
Q3 | $7.6M | Buy |
45,820
+11,456
| +33% | +$1.9M | 0.5% | 77 |
|
|
2015
Q2 | $8.3M | Sell |
34,364
-4,435
| -11% | -$1.07M | 0.64% | 62 |
|
|
2015
Q1 | $10.4M | Sell |
38,799
-1,428
| -4% | -$382K | 0.85% | 45 |
|
|
2014
Q4 | $6.28M | Buy |
+40,227
| New | +$6.28M | 0.54% | 69 |
|
|
2014
Q3 | – | Sell |
-16,248
| Closed | -$3.85M | – | 236 |
|
|
2014
Q2 | $3.85M | Sell |
16,248
-10,573
| -39% | -$2.5M | 0.35% | 98 |
|
|
2014
Q1 | $8.85M | Sell |
26,821
-73,896
| -73% | -$24.4M | 0.85% | 42 |
|
|
2013
Q4 | $11.4M | Buy |
100,717
+10,136
| +11% | +$1.14M | 0.68% | 55 |
|
|
2013
Q3 | $6.25M | Buy |
90,581
+67,105
| +286% | +$4.63M | 0.86% | 41 |
|
|
2013
Q2 | $1.05M | Buy |
+23,476
| New | +$1.05M | 0.18% | 125 |
|